MedTrace Logo

Research on Risk Assessment and Early Warning Models for Adverse Clinical Outcomes in Critically Ill Patients

NCT07317817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55940

Last updated 2026-01-05

No results posted yet for this study

Summary

This is a medical research study that uses information from past patient hospital records. It focuses on three serious conditions that often affect critically ill patients: sepsis (a life-threatening body-wide infection), ARDS (a severe lung injury that makes breathing very difficult), and acute kidney injury (sudden loss of kidney function). The goal is to better understand which patients in the ICU are at highest risk of developing these conditions or getting worse. Researchers will look at de-identified information from medical records of patients treated in the ICU . The study will use computer analysis to find patterns in the data that may help doctors predict these risks earlier. No new treatments are being tested, and no patients will be contacted or recruited for this study. All data used is anonymous to protect patient privacy.

Conditions

  • Sepsis
  • ARDS (Acute Respiratory Distress Syndrome)
  • AKI - Acute Kidney Injury

Interventions

OTHER

No intervention (Observational study)

This is a non-interventional, observational study. The aim is to develop and validate a predictive model using existing clinical data. No medical interventions (such as drugs, devices, or procedures) are being administered, assigned, or compared as part of this research protocol. The "intervention" of interest is the application of the predictive model for risk assessment, which is an analytical procedure, not a patient-directed intervention.

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317817 on ClinicalTrials.gov